A new study warns that patients who have suffered recent strokes may face a higher risk of retaining potentially toxic gadolinium deposits in the brain after receiving MRI contrast dyes,…
A new study finds that older, linear gadolinium contrast agents appear to have a much higher risk of leaving behind high levels of gadolinium in the brain.
Changes in children's brains may make them more susceptible to gadolinium retention after the age of two, according to the findings of a new study.
A new study indicates that linear gadolinium contrast dyes leave deposits of the chemical in rat brains for at least a year.
Growing evidence suggests some types of MRI contrast dyes may be more prone to leave behind traces of gadolinium in the human body.
A gadolinium contrast dye lawsuit indicates that a woman suffered severe allergic reactions and hospitalization after being injected with Gadavist before a brain MRI.
Mayo Clinic researchers indicate that gadolinium can accumulate in the cerebrospinal fluid and penetrate the brain blood barrier when used as contrast dyes to enhance MRI scans.
A number of gadolinium toxicity lawsuits have been transferred out of the Northern District of California federal court to states where the plaintiffs reside.
Radiologists often fail to report scans indicating a build up of gadolinium contrast agents in patients' brains, according to a new study.
The FDA is requiring new label warnings for gadolinium-based MRI contrast agents, due to retention of gadolinium in the body.
